Celldex to Present at Upcoming Investor Conferences
Key Highlights
- ➤Celldex (CLDX) management to participate in two upcoming healthcare investor conferences
- ➤Guggenheim fireside chat scheduled for November 9, 2026, at 9:00am ET
- ➤Evercore fireside chat scheduled for December 1, 2026, at 10:50am ET
- ➤Conference presentation webcasts and 90-day replays available on Celldex’s investor website
HAMPTON, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming investor conferences: * The Guggenheim 3(rd) Annual Healthcare Innovation Conference on November 9, 2026 at 9:00am ET. * The 9(th) Annual Evercore Healthcare Conference on December 1, 2026 at 10:50am ET. The webcasts of the Guggenheim and Evercore presentations will be available on the “Events and Presentations” page of the “Investors” section of the Celldex Website. Replays will be available for 90 days following the event.
About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.
Get started
Create a free account to read the full story.